Xenon Pharmaceuticals Inc’s recently made public that its Chief Financial Officer AULIN SHERRY unloaded Company’s shares for reported $0.77 million on Dec 18 ’24. In the deal valued at $41.21 per share,18,709 shares were sold. As a result of this transaction, AULIN SHERRY now holds 0 shares worth roughly $0.0.
Then, SHERRY AULIN bought 18,709 shares, generating $770,909 in total proceeds.
Before that, PATOU GARY sold 4,891 shares. Xenon Pharmaceuticals Inc shares valued at $200,947 were divested by the Director at a price of $41.08 per share. As a result of the transaction, PATOU GARY now holds 23,573 shares, worth roughly $0.91 million.
A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early October with a ‘”a Buy”‘ rating. Citigroup began covering XENE with “Buy” recommendation on January 04, 2024. Robert W. Baird started covering the stock on December 08, 2023. It rated XENE as “an Outperform”.
Price Performance Review of XENE
On Tuesday, Xenon Pharmaceuticals Inc [NASDAQ:XENE] saw its stock jump 0.73% to $38.42. Over the last five days, the stock has lost -3.10%. Xenon Pharmaceuticals Inc shares have fallen nearly -13.16% since the year began. Nevertheless, the stocks have fallen -10.37% over the past one year. While a 52-week high of $50.99 was reached on 03/01/24, a 52-week low of $35.53 was recorded on 06/26/24. SMA at 50 days reached $41.68, while 200 days put it at $40.78.
Levels Of Support And Resistance For XENE Stock
The 24-hour chart illustrates a support level at 37.77, which if violated will result in even more drops to 37.11. On the upside, there is a resistance level at 38.92. A further resistance level may holdings at 39.41. The Relative Strength Index (RSI) on the 14-day chart is 46.68, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.07, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.64%. Stochastics %K at 14.96% indicates the stock is a buying.
How much short interest is there in Xenon Pharmaceuticals Inc?
A steep rise in short interest was recorded in Xenon Pharmaceuticals Inc stocks on 2024-10-31, dropping by -0.41 million shares to a total of 2.89 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 3.3 million shares. There was a decline of -14.3%, which implies that there is a negative sentiment for the stock.
